Lismore Damian T.

CIK 00015608641 companyBLACKROCK, L2

SEC Profile

Transactions

Companies

Filings

CIK

0001560864

Recent Transactions

31 trades

Disposition to Issuer
Nexvet Biopharma plc
Ordinary Shares
2017-07-31$6.72/sh−67,750→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Ordinary Shares
2017-07-31$6.72/sh−18,724→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Option to Purchase Shares
2017-07-31−100,000→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Restricted Share Units
2017-07-31$6.59/sh−27,500→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Restricted Share Units
2017-07-31$6.59/sh−48,750→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Ordinary Shares
2017-07-31$6.72/sh−21,239→ 0 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2017-07-01−16,250→ 48,750 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+16,250→ 63,750 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+13,750→ 47,500 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2017-07-01−7,079→ 0 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2017-07-01−4,000→ 0 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+4,000→ 67,750 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+7,079→ 21,239 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2016-09-05−65,000→ 27,500 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2016-09-05+65,000→ 65,000 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2016-07-01$0.13/sh+13,750→ 33,750 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2016-07-01−13,750→ 41,250 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2016-07-01$0.13/sh+4,000→ 20,000 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2016-07-01−4,000→ 4,000 total
Purchase
Nexvet Biopharma plc
Ordinary Shares
2016-02-18$3.22/sh+5,000→ 18,724 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2015-11-23−6,000→ 8,000 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-11-23$0.13/sh+6,000→ 16,000 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-11-17$0.13/sh+7,080→ 14,160 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2015-11-17−7,080→ 7,079 total
Award
Nexvet Biopharma plc
Restricted Share Units
2015-09-03+55,000→ 55,000 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-07-01$0.13/sh+4,000→ 10,000 total
Exercise/Conversion
Nexvet Biopharma plc
Options to Purchase Stock
2015-07-01−4,000→ 14,000 total
Award
Nexvet Biopharma plc
Ordinary Shares
2015-06-08$0.13/sh+6,000→ 6,000 total
Award
Nexvet Biopharma plc
Option to Purchase Shares
2015-05-18+100,000→ 100,000 total
Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-02-10+13,724→ 13,724 total
Conversion
Nexvet Biopharma plc
Series B Preference Shares
2015-02-10−13,724→ 0 total

Companies

Nexvet Biopharma plc
Chief Financial Officer

Recent Filings

Address

C/O NEXVET BIOPHARMA PLC NIBRT; FOSTERS AVENUE, MOUNT MERRION

BLACKROCK, L2

View on SEC.gov